Compare McKesson Corporation (MCK) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs AT&T Inc. — how do they compare? McKesson Corporation trades at $825.97 (market cap $97.35B), while AT&T Inc. trades at $21.91 (market cap $152.52B). The key difference: AT&T Inc. is the larger of the two by market cap, and AT&T Inc. pays the higher dividend (5.06%). Which is the better fit depends on your goals.
| MCK | T | |
|---|---|---|
Market Cap | $97.35B | $152.52B |
Sector | Health | Media |
52-Week High | $995.69 | $29.62 |
52-Week Low | $659.01 | $20.49 |
Enterprise Value | $101.98B | $297.87B |
Dividend Yield | 0.39% | 5.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
AT&T (T) trades at $21.91, up 0.52% today, with a bullish technical signal and strong fundamentals including a 17.47% net income margin and consistent earnings beats. The stock shows improving cash flow trends, with net cash flow turning positive to $15.12B in 2025. Recent news highlights fiber expansion and competitive threats from Starlink, while analyst consensus leans toward a buy with a $26.18 price target.
The outlook is cautiously optimistic given attractive valuation multiples like a P/E of 7.34 and a 19.95% ROE, but risks include intense telecom competition and debt levels. The stock offers a dividend yield supported by sustainable cash flows, positioning it as a value play with moderate growth potential amid industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
